STAT

Opinion: Pork farming: the next battlefield for fighting antibiotic resistance

In its four-month journey from piglet to slaughter, each of the nearly 1 billion pigs on the planet will consume 2.5 times the amount of antibiotics as the average European…
Source: GREG BAKER/AFP/Getty Images

McDonald’s recently announced it will begin phasing out the use of medically important antibiotics in its global beef supply chain, building on its experience phasing out such antibiotics from its chicken supply. Other retail food chains have also made progress. Now it’s time to take aim at pork.

McDonald’s promise is a commendable step in addressing antimicrobial resistance, one of our most pressing global health challenges. It’s also an important signal that consumers hold power to shift food industry practices toward sustainability.

Nearly a century ago, Alexander Fleming’s discovery of penicillin launched modern medical practice into the antibiotic era. His discovery, and those that followed, are credited with saving untold millions of lives and enabling landmark medical breakthroughs. Yet decades of inattentive use — for purposes as different as treating viral infections, for which antibiotics are ineffective, to the industrial production of beef, chicken, pork, and seafood — now risks throwing away the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks